2021 | Disparate treatment outcomes according to presence of pathogenic mutations in West syndrome | 최한솜 | Article |
2013 | Fisetin inhibits matrix metalloproteinases and reduces tumor cell invasiveness and endothelial cell tube formation | 김화정 | Article |
2009 | Hemoglobin yamagata: Hemoglobin variant detected by HbA1c test | 홍기숙; 이미애; 성연아; 정화순 | Article |
2018 | Leptin regulates the pro-inflammatory response in human epidermal keratinocytes | 임경민 | Article |
2017 | Processing of syndecan-2 by matrix metalloproteinase-14 and effect of its cleavage on VEGF-induced tube formation of HUVECs | 오억수 | Article |
2010 | Roles of arrest-defective protein 1225 and hypoxia-inducible factor 1α in tumor growth and metastasis | 오구택; 이미니 | Article |
2017 | Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ–mediated FAK/ERK signaling pathway in colon cancer | 오억수 | Article |
2009 | Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells | 오억수 | Article |
2012 | The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells | 오억수 | Article |
2013 | The presence of outer arm fucose residues on the N -glycans of tissue inhibitor of metalloproteinases-1 reduces its activity | 김화정 | Article |
2003 | TIMP-1 inhibits apoptosis in breast carcinoma cells via a pathway involving pertussis toxin-sensitive G protein and c-Src | 김화정; 배윤수 | Article |
1999 | Tissue Inhibitor of Metalloproteinases-2 Inhibits the 4-Aminophenylmercuric Acetate-Induced Activation and Autodegradation of the Free Promatrix Metalloproteinase-2 | 김화정 | Article |
2019 | Tyrosine 51 residue of the syndecan-2 extracellular domain is involved in the interaction with and activation of pro-matrix metalloproteinase-7 | 오억수; 신동해; 장보희 | Article |